Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slikkerveer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Toxicology and Adverse Drug Experience|September 1, 1989
Pharmacokinetics and toxicity of bismuth compoundsA Slikkerveer, F A de Wolff
Journal of Toxicology. Clinical Toxicology|January 1, 1993
Bismuth poisoning and chelationA Slikkerveer, F A de Wolff
Clinical Chemistry|May 1, 1993
Analysis for bismuth in tissue by electrothermal atomic absorption spectrometryA Slikkerveer, R B Helmich, F A de Wolff
Biochemical Pharmacology|February 1, 1991
The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?P J Boogaard, A Slikkerveer, J F Nagelkerke, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1992
Development of a therapeutic procedure for bismuth intoxication with chelating agentsA Slikkerveer, H B Jong, R B Helmich, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
Absorption of bismuth from several bismuth compounds during in vivo perfusion of rat small intestineA Slikkerveer, R B Helmich, G B van Der Voet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 14, 1991
Analysis of bismuth in serum and blood by electrothermal atomic absorption spectrometry using platinum as matrix modifierA Slikkerveer, R B Helmich, P M Edelbroek, et al.
The Analyst|May 15, 1998
Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acidA Slikkerveer, L A Noach, G N Tytgat, et al.
Archives of Toxicology|October 24, 2000
Bismuth biokinetics and kidney histopathology after bismuth overdose in ratsB T Leussink, A Slikkerveer, W J Krauwinkel, et al.
Toxicology and Applied Pharmacology|August 18, 2001
Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicityB T Leussink, S V Litvinov, E de Heer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Toxicology and Adverse Drug Experience|September 1, 1989
Pharmacokinetics and toxicity of bismuth compoundsA Slikkerveer, F A de Wolff
Journal of Toxicology. Clinical Toxicology|January 1, 1993
Bismuth poisoning and chelationA Slikkerveer, F A de Wolff
Clinical Chemistry|May 1, 1993
Analysis for bismuth in tissue by electrothermal atomic absorption spectrometryA Slikkerveer, R B Helmich, F A de Wolff
Biochemical Pharmacology|February 1, 1991
The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding?P J Boogaard, A Slikkerveer, J F Nagelkerke, et al.
The Journal of Laboratory and Clinical Medicine|May 1, 1992
Development of a therapeutic procedure for bismuth intoxication with chelating agentsA Slikkerveer, H B Jong, R B Helmich, et al.
Journal of Pharmaceutical Sciences|April 1, 1995
Absorption of bismuth from several bismuth compounds during in vivo perfusion of rat small intestineA Slikkerveer, R B Helmich, G B van Der Voet, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 14, 1991
Analysis of bismuth in serum and blood by electrothermal atomic absorption spectrometry using platinum as matrix modifierA Slikkerveer, R B Helmich, P M Edelbroek, et al.
The Analyst|May 15, 1998
Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acidA Slikkerveer, L A Noach, G N Tytgat, et al.
Archives of Toxicology|October 24, 2000
Bismuth biokinetics and kidney histopathology after bismuth overdose in ratsB T Leussink, A Slikkerveer, W J Krauwinkel, et al.
Toxicology and Applied Pharmacology|August 18, 2001
Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicityB T Leussink, S V Litvinov, E de Heer, et al.
Pageof 2